SMT's Supraflex Cruz Coronary Stent Receives Health Canada Approval
Sahajanand Medical Technologies Limited (SMT) has received a Class IV medical device license from Health Canada for its Supraflex Cruz sirolimus-eluting coronary stent system, allowing its import and sale in Canada. This approval marks SMT's entry into the North American market and supports its strategy to expand access to coronary-intervention technologies. Heart disease remains a leading health concern in Canada, with significant prevalence and mortality rates. SMT aims to assist physicians treating coronary artery disease through this licensed device.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 48/100.
Outlets measured: news18, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 9 Sept, 06:46 am. Other outlets followed.
- 1